Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB3834
CAS No: 660817-08-3
Chemical Name: N,1-Bis(4-nitrophenyl)-5-phenyl-1H-1,2,3-Triazole-4-carboxamide
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $26.55 | Total: $2,655.00 |
1 | 50 | $30.68 | Total: $1,534.00 |
1 | 25 | $35.99 | Total: $899.75 |
1 | 10 | $42.48 | Total: $424.80 |
1 | 5 | $50.15 | Total: $250.75 |
Molecular Formula | C21H14N6O5 |
Molecular Weight | 430.37 |
CAS Numbers | 660817-08-3 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO |
Purity | 98% by HPLC |
Synonym | CAP-53194; CAP 53194; CAP53194; |
IUPAC/Chemical Name | N,1-Bis(4-nitrophenyl)-5-phenyl-1H-1,2,3-Triazole-4-carboxamide |
InChl Key | ORYIDPDQYDBZQA-UHFFFAOYSA-N |
InChl Code | InChI=1S/C21H14N6O5/c28-21(22-15-6-8-17(9-7-15)26(29)30)19-20(14-4-2-1-3-5-14)25(24-23-19)16-10-12-18(13-11-16)27(31)32/h1-13H,(H,22,28) |
SMILES Code | O=C(C1=C(C2=CC=CC=C2)N(C3=CC=C([N+]([O-])=O)C=C3)N=N1)NC4=CC=C([N+]([O-])=O)C=C4 |
References | 1) Shino N, Uchida T, Yoshida M, Nomura Y. Development and Assessment of a Nomogram to Propose the Initial Dosage Regimen of a Meropenem Infusion Based on Serum Creatinine and Age Using a Monte Carlo Simulation. Chem Pharm Bull (Tokyo). 2015;63(12):986-91. 2) Wang L, Kim M, Fang Q, Min J, Jeon WI, Lee SY, Son SJ, Joo SW, Lee SB. Hydrophobic end-gated silica nanotubes for intracellular glutathione-stimulated drug delivery in drug-resistant cancer cells. Chem Commun (Camb). 2013 Apr 21;49(31):3194-6. |
Novel potent and selective Plk1 inhibitor